Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sannah Jensen Zoffmann is active.

Publication


Featured researches published by Sannah Jensen Zoffmann.


Nature Cell Biology | 2014

White-to-brown metabolic conversion of human adipocytes by JAK inhibition

Annie Moisan; Youn-Kyoung Lee; Jitao David Zhang; Carolyn S. Hudak; Claas Aiko Meyer; Michael Prummer; Sannah Jensen Zoffmann; Hoa Hue Truong; Martin Ebeling; Anna Kiialainen; Régine Gérard; Fang Xia; Robert T. Schinzel; Kurt E. Amrein; Chad A. Cowan

The rising incidence of obesity and related disorders such as diabetes and heart disease has focused considerable attention on the discovery of new therapeutics. One promising approach has been to increase the number or activity of brown-like adipocytes in white adipose depots, as this has been shown to prevent diet-induced obesity and reduce the incidence and severity of type 2 diabetes. Thus, the conversion of fat-storing cells into metabolically active thermogenic cells has become an appealing therapeutic strategy to combat obesity. Here, we report a screening platform for the identification of small molecules capable of promoting a white-to-brown metabolic conversion in human adipocytes. We identified two inhibitors of Janus kinase (JAK) activity with no precedent in adipose tissue biology that stably confer brown-like metabolic activity to white adipocytes. Importantly, these metabolically converted adipocytes exhibit elevated UCP1 expression and increased mitochondrial activity. We further found that repression of interferon signalling and activation of hedgehog signalling in JAK-inactivated adipocytes contributes to the metabolic conversion observed in these cells. Our findings highlight a previously unknown role for the JAK–STAT pathway in the control of adipocyte function and establish a platform to identify compounds for the treatment of obesity.


Stem cell reports | 2014

Chemical Conversion of Human Fibroblasts into Functional Schwann Cells

Eva C. Thoma; Claudia Merkl; Tobias Heckel; Rachel Haab; Frédéric Knoflach; Corinne Nowaczyk; Nicholas Flint; Ravi Jagasia; Sannah Jensen Zoffmann; Hoa Hue Truong; Pascal Petitjean; Sebastian Jessberger; Martin Graf; Roberto Iacone

Summary Direct transdifferentiation of somatic cells is a promising approach to obtain patient-specific cells for numerous applications. However, conversion across germ-layer borders often requires ectopic gene expression with unpredictable side effects. Here, we present a gene-free approach that allows efficient conversion of human fibroblasts via a transient progenitor stage into Schwann cells, the major glial cell type of peripheral nerves. Using a multikinase inhibitor, we transdifferentiated fibroblasts into transient neural precursors that were subsequently further differentiated into Schwann cells. The resulting induced Schwann cells (iSCs) expressed numerous Schwann cell-specific proteins and displayed neurosupportive and myelination capacity in vitro. Thus, we established a strategy to obtain mature Schwann cells from human postnatal fibroblasts under chemically defined conditions without the introduction of ectopic genes.


Cell Reports | 2016

mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis

Veronica Costa; Stefan Aigner; Mirko Vukcevic; Evelyn Sauter; Katharina Behr; Martin Ebeling; Tom Dunkley; Arno Friedlein; Sannah Jensen Zoffmann; Claas Aiko Meyer; Frédéric Knoflach; Sebastian Lugert; Christoph Patsch; Fatiha Fjeldskaar; Laurie Chicha-Gaudimier; Anna Kiialainen; Paolo Piraino; Marc Bedoucha; Martin Graf; Sebastian Jessberger; Anirvan Ghosh; Josef Bischofberger; Ravi Jagasia

Hyperfunction of the mTORC1 pathway has been associated with idiopathic and syndromic forms of autism spectrum disorder (ASD), including tuberous sclerosis, caused by loss of either TSC1 or TSC2. It remains largely unknown how developmental processes and biochemical signaling affected by mTORC1 dysregulation contribute to human neuronal dysfunction. Here, we have characterized multiple stages of neurogenesis and synapse formation in human neurons derived from TSC2-deleted pluripotent stem cells. Homozygous TSC2 deletion causes severe developmental abnormalities that recapitulate pathological hallmarks of cortical malformations in patients. Both TSC2(+/-) and TSC2(-/-) neurons display altered synaptic transmission paralleled by molecular changes in pathways associated with autism, suggesting the convergence of pathological mechanisms in ASD. Pharmacological inhibition of mTORC1 corrects developmental abnormalities and synaptic dysfunction during independent developmental stages. Our results uncouple stage-specific roles of mTORC1 in human neuronal development and contribute to a better understanding of the onset of neuronal pathophysiology in tuberous sclerosis.


Journal of Molecular Endocrinology | 2013

Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and man

Franziska Boess; Cristina Bertinetti-Lapatki; Sannah Jensen Zoffmann; Catherine George; Thomas Pfister; Adrian Roth; Serene M L Lee; Wolfgang E Thasler; Thomas Singer; Laura Suter

Glucagon-like peptide 1 (GLP1) analogs have been associated with an increased incidence of thyroid C-cell hyperplasia and tumors in rodents. This effect may be due to a GLP1 receptor (GLP1R)-dependent mechanism. As the expression of GLP1R is much lower in primates than in rodents, the described C-cell proliferative lesions may not be relevant to man. Here, we aimed to establish primary thyroid cell cultures of rat and human to evaluate the expression and function of GLP1R in C-cells. In our experiments, GLP1R expression was observed in primary rat C-cells (in situ hybridization) but was not detected in primary human C-cells (mRNA and protein levels). The functional response of the cultures to the stimulation with GLP1R agonists is an indirect measure of the presence of functional receptor. Liraglutide and taspoglutide elicited a modest increase in calcitonin release and in calcitonin expression in rat primary thyroid cultures. Contrarily, no functional response to GLP1R agonists was observed in human thyroid cultures, despite the presence of few calcitonin-positive C-cells. Thus, the lack of functional response of the human cultures adds to the weight of evidence indicating that healthy human C-cells have very low levels or completely lack GLP1R. In summary, our results support the hypothesis that the GLP1R agonist-induced C-cell responses in rodents may not be relevant to primates. In addition, the established cell culture method represents a useful tool to study the physiological and/or pathological roles of GLP1 and GLP1R agonists on normal, non-transformed primary C-cells from rats and man.


Biophysical Journal | 2012

A random motility assay based on image correlation spectroscopy.

Michael Prummer; Dorothee Kling; Vanessa Trefzer; Thilo Enderle; Sannah Jensen Zoffmann; Marco Prunotto

We demonstrate the random motility (RAMOT) assay based on image correlation spectroscopy for the automated, label-free, high-throughput characterization of random cell migration. The approach is complementary to traditional migration assays, which determine only the collective net motility in a particular direction. The RAMOT assay is less demanding on image quality compared to single-cell tracking, does not require cell identification or trajectory reconstruction, and performs well on live-cell, time-lapse, phase contrast video microscopy of hundreds of cells in parallel. Effective diffusion coefficients derived from the RAMOT analysis are in quantitative agreement with Monte Carlo simulations and allowed for the detection of pharmacological effects on macrophage-like cells migrating on a planar collagen matrix. These results expand the application range of image correlation spectroscopy to multicellular systems and demonstrate a novel, to our knowledge, migration assay with little preparative effort.


Chemistry & Biology | 2017

Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug Discovery

Faye Drawnel; Jitao David Zhang; Erich Küng; Natsuyo Aoyama; Fethallah Benmansour; Andrea Araujo Del Rosario; Sannah Jensen Zoffmann; Frédéric Delobel; Michael Prummer; Franziska Weibel; Coby B. Carlson; Blake Anson; Roberto Iacone; Ulrich Certa; Thomas Singer; Martin Ebeling; Marco Prunotto


Archive | 2005

Ligand-receptor tracking assays

Christian M. Apfel; Thilo Enderle; Sannah Jensen Zoffmann; Mireille Penski


Archive | 2004

Fluorescently labeled growth hormone secretagogue

Thilo Enderle; Martin Graf; Cornelia Hertel; Sannah Jensen Zoffmann; Eric Argirios Kitas


Archive | 2006

TRITIATED GROWTH HORMONE SECRETAGOGUE MK-0677

Cornelia Hertel; Philipp Huguenin; Sannah Jensen Zoffmann; Jean-Marc Plancher


Archive | 2005

Assay for tracing ligand receptor

Christian M. Apfel; Thilo Enderle; Mireille Moser; Sannah Jensen Zoffmann; アプフェル クリスチャン; ジェンセン ゾフマン サーナ; エンデリー ティロ; モーザー ミレーユ

Collaboration


Dive into the Sannah Jensen Zoffmann's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge